Factors associated with time interval between the onset of symptoms and first medical visit in women with breast cancer.
Factors associated with time interval between the onset of symptoms and first medical visit in women with breast cancer. Cad Saude Publica. 2020;36(2):e00011919 Authors: Barros ÂF, Murta-Nascimento C, Abdon CH, Nogueira DN, Lopes ELC, Dias A Abstract Women presenting with advanced breast cancer tumors are common in Brazil. Little is known about factors contributing to the delay in seeking care. The aim of this study was to identify factors associated with longer time intervals between the onset of breast cancer symptoms and the first medical visit in the Federal District, Brazil. The analysis included 444 symptomatic women with incident breast cancer, interviewed between September, 2012 and September, 2014, during their admission for breast cancer treatment in nine public hospitals in the Federal District. Patients with metastatic disease at diagnosis were not included in this study. The outcome was time interval between symptom onset and the first medical visit, whether> 90 (34% of patients) or ≤ 90 days. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (95%CI). In the multivariate analysis, the> 90 day interval was significantly associated with patients not performing mammography and/or breast ultrasound in the two years prior to breast cancer diagnosis (OR = 1.97; 95%CI: 1.26-3.08), and with more advanced stages (OR = 1.72; 95%CI: 1.10-2.72). Furthermore, there was a lower chance of delay in patient...
Shortened protocol identifies more cancers than ultrasound or mammography.
Diagnostic mammography is effective on its own for evaluating palpable breast...Read more on AuntMinnie.comRelated Reading: Ultrasound performance mixed in breast cancer survivors Deep-learning algorithm helps assess dense breasts Supplemental dense breast screening practices vary WISDOM breast cancer screening study now open to all Hey, Alexa -- Tell me about breast density
Ultrasound is often used as a supplement for mammography to detect breast cancer. However, one known limitation is the high false-positive rates associated with breast ultrasound. We investigated the use of coherence-based beamforming (which directly displays spatial coherence) as a supplement to standard ultrasound B-mode images in 25 patients recommended for biopsy (26 masses in total), with the eventual goal of decreasing false-positive rates. Because of the coherent signal present within solid masses, coherence-based beamforming methods allow solid and fluid-filled masses to appear significantly different (p
Barranger E Abstract OBJECTIVES: To evaluate the impact of systematic radiological review by breast specialist radiologist of malignant breast lesion imaging on the therapeutic management of patients. MATERIALS AND METHODS: Data collection was performed for patients with histopathologically proved breast cancer or suspicious breast lesion on imaging realized out of our institution. Patients underwent systematic mammary and axillary ultrasound, imaging review and if necessary complementary mammographic images. We analyzed the number of additional breast biopsies and axillary lymph node fine needle aspiration (...
ConclusionsUS may underestimate breast tumor size. Treatment decisions that take into account tumor size can be made equally reliably in patients with high or low breast density.
ConclusionsThe obtained results showed that the proposed method was quite efficient in histopathological image classification. Despite the relative simplicity of the approach, the obtained results were far superior to previously reported results.Graphical abstract
ConclusionsCancers were predominantly detected in women undergoing preoperative staging of new invasive lobular carcinoma in the contralateral breast, rather than the Medicare rebate ‐eligible high‐risk screening group.
An artificial intelligence (AI) algorithm trained with a large set of mammography...Read more on AuntMinnie.comRelated Reading: CEDM excels as presurgical diagnosis tool in large study WISDOM breast cancer screening study now open to all Digital mammo for microcalcifications: A mixed bag? Are women with depression less likely to get mammograms? AI helps characterize breast masses on ultrasound
AbstractBreast cancer is the most common type of malignancy diagnosed in women. Through early detection and diagnosis, there is a great chance of recovery and thereby reduce the mortality rate. Many preliminary tests like non-invasive radiological diagnosis using ultrasound, mammography, and MRI are widely used for the diagnosis of breast cancer. However, histopathological analysis of breast biopsy specimen is inevitable and is considered to be the golden standard for the affirmation of cancer. With the advancements in the digital computing capabilities, memory capacity, and imaging modalities, the development of computer-...
Conclusions The dedicated B-CT provides high-quality images. It can be used as alternative particularly in those patients not otherwise willing to perform mammography because of the breast compression.